These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11353816)

  • 41. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
    Lang TT; Young JD; Cass CE
    Mol Pharmacol; 2004 Apr; 65(4):925-33. PubMed ID: 15044622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism of capecitabine, an oral fluorouracil prodrug: (19)F NMR studies in animal models and human urine.
    Desmoulin F; Gilard V; Malet-Martino M; Martino R
    Drug Metab Dispos; 2002 Nov; 30(11):1221-9. PubMed ID: 12386128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mechanism and possible biochemical modulation of capecitabine (Xeloda), a newly generated oral fluoropyrimidine].
    Saeki T; Takashima S
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):447-55. PubMed ID: 10097741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes.
    Fischel JL; Formento P; Ciccolini J; Etienne-Grimaldi MC; Milano G
    Anticancer Drugs; 2004 Nov; 15(10):969-74. PubMed ID: 15514566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer.
    Yamaue H; Tanimura H; Kono N; Aoki Y; Tabuse K; Uchiyama K; Takifuji K; Iwahashi M; Tani M
    Anticancer Res; 2003; 23(3B):2559-64. PubMed ID: 12894541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrophysiological characterization of the human Na(+)/nucleoside cotransporter 1 (hCNT1) and role of adenosine on hCNT1 function.
    Larráyoz IM; Casado FJ; Pastor-Anglada M; Lostao MP
    J Biol Chem; 2004 Mar; 279(10):8999-9007. PubMed ID: 14701834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation.
    Rius M; Stresemann C; Keller D; Brom M; Schirrmacher E; Keppler D; Lyko F
    Mol Cancer Ther; 2009 Jan; 8(1):225-31. PubMed ID: 19139132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Transfection of thymidine phosphorylase cDNA with lentiviral vector enhances the anticancer effect of 5'-deoxy-5-fluorouridine on colorectal cancer cell lines HT29 and LS174T].
    Ye D; Wang Q; Zhang J; Liu Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):18-24. PubMed ID: 25877313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients.
    Poole C; Gardiner J; Twelves C; Johnston P; Harper P; Cassidy J; Monkhouse J; Banken L; Weidekamm E; Reigner B
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):225-34. PubMed ID: 11935215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of introduction of dThdPase cDNA on sensitivity to 5'-deoxy-5-fluorouridine and tumor angiogenesis.
    Kim R; Murakami S; Toge T
    Int J Oncol; 2003 Apr; 22(4):835-41. PubMed ID: 12632076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative determination of capecitabine and its six metabolites in human plasma using liquid chromatography coupled to electrospray tandem mass spectrometry.
    Deenen MJ; Rosing H; Hillebrand MJ; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan; 913-914():30-40. PubMed ID: 23270936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.
    Di Gennaro E; Piro G; Chianese MI; Franco R; Di Cintio A; Moccia T; Luciano A; de Ruggiero I; Bruzzese F; Avallone A; Arra C; Budillon A
    Br J Cancer; 2010 Nov; 103(11):1680-91. PubMed ID: 21045833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative antitumor activity of 5-fluorouracil and its prodrugs in combination with hyperthermia in vitro.
    Shiiki S; Fuchimoto S; Iwagaki H; Akazai Y; Matsubara N; Watanabe T; Orita K
    Acta Med Okayama; 1991 Oct; 45(5):339-45. PubMed ID: 1836706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ZRX1, the first EGFR inhibitor-capecitabine based combi-molecule, requires carboxylesterase-mediated hydrolysis for optimal activity.
    Ait-Tihyaty M; Rachid Z; Larroque-Lombard AL; Jean-Claude BJ
    Invest New Drugs; 2013 Dec; 31(6):1409-23. PubMed ID: 23959266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA.
    Kato Y; Matsukawa S; Muraoka R; Tanigawa N
    Br J Cancer; 1997; 75(4):506-11. PubMed ID: 9052401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population pharmacokinetic analysis of the major metabolites of capecitabine.
    Gieschke R; Reigner B; Blesch KS; Steimer JL
    J Pharmacokinet Pharmacodyn; 2002 Feb; 29(1):25-47. PubMed ID: 12194534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.
    Miwa M; Ura M; Nishida M; Sawada N; Ishikawa T; Mori K; Shimma N; Umeda I; Ishitsuka H
    Eur J Cancer; 1998 Jul; 34(8):1274-81. PubMed ID: 9849491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disposition and availability of 5-fluorouracil prodrug 5'-deoxy-5-fluorouridine after oral administration in rats.
    Au JL
    J Pharm Sci; 1987 Sep; 76(9):699-702. PubMed ID: 11002805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Capecitabine (Xeloda): from the laboratory to the patient's home.
    Pentheroudakis G; Twelves C
    Clin Colorectal Cancer; 2002 May; 2(1):16-23. PubMed ID: 12453332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon-α enhances 5'-deoxy-5-fluorouridine-induced apoptosis by ERK-dependant upregulation of thymidine phosphorylase.
    Zhu Y; Xu L; Fan Y; Li C; Zhang Y; Zheng H; Hou K; Qu X; Liu Y
    Biomed Res Int; 2013; 2013():132793. PubMed ID: 24027750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.